Source: BIOSPACE

Hapten Sciences: <b>Hapten Sciences</b> to Begin Clinical Trials for Novel Poison Ivy Vaccine

Life Sciences Jobs ...

Read full article »
Hapten Sciences's Competitors | Hapten Sciences's News | Hapten Sciences's Financials
Stay up-to-date with the latest news on Hapten Sciences
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Raymond J Hage's photo - President & CEO of Hapten Sciences

President & CEO

Raymond J Hage

CEO Approval Rating

85/100

Read more
Stay up-to-date with the latest news on Hapten Sciences